Prenatal Corticosteroid Prophylaxis for Women Delivering at Late Preterm Gestation

Author:

Joseph K. S.12,Nette Farrell1,Scott Heather1,Vincer Michael J.2

Affiliation:

1. Departments of Obstetrics and Gynaecology and School of Population and Public Health, University of British Columbia and British Columbia's Women's Hospital and Health Centre, Vancouver, British Columbia, Canada

2. Pediatrics, Dalhousie University and the Izaak Walton Killam Health Centre, Halifax, Canada

Abstract

OBJECTIVE: We studied patterns of prenatal corticosteroid use, respiratory distress syndrome, and associated mortality rates to assess the congruence between knowledge and clinical practice related to such prophylaxis. METHODS: We used data on all live births in the United States (for the years 1989–1991, 1995–1997, and 2002–2004) and Nova Scotia, Canada (for the years 1988–2007). Gestational age-specific temporal trends in infant deaths resulting from respiratory distress syndrome were quantified in the United States, and gestational age-specific temporal trends in corticosteroid use and morbidity (respiratory distress syndrome and intraventricular hemorrhage) were quantified in Nova Scotia. RESULTS: In the United States, infant deaths associated with respiratory distress syndrome decreased by 48% (95% confidence interval: 46%–50%) from 1989–1991 to 1995–1997 and then decreased by another 18% (95% confidence interval: 15%–22%) by 2002–2004. The latter mortality reduction was evident at 28 to 32 weeks but not 33 to 36 weeks of gestation. Corticosteroid use at 28 to 32 weeks was high in Nova Scotia and increased from 30.7% in 1988–1989 to 50.0% in 1996–1997 and to 52.9% in 2006–2007, whereas rates of use at 33 to 36 weeks were much lower (eg, 6.7%, 17.0%, and 15.7% at 34 weeks in the 3 periods). Increased corticosteroid use at 33 and 34 weeks was estimated to reduce respiratory distress syndrome substantially. CONCLUSION: Addressing the knowledge-practice gap in corticosteroid use at 33 to 34 weeks should reduce infant morbidity and mortality rates.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Reference31 articles.

1. National Institute of Child Health and Human Development. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement. 1994;12(2):1–24

2. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Committee Opinion 147: antenatal corticosteroid therapy for fetal maturation. Int J Gynaecol Obstet. 1995;48(3):340–342

3. National Institutes of Health. Antenatal corticosteroids revisited: repeat courses. NIH Consens Statement. 2000;17(2):1–10

4. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;(3):CD004454

5. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC III, Hauth JC, Wenstrom KD, eds. Williams Obstetrics. 21st ed. Toronto, Canada: McGraw-Hill; 2001

Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3